Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Ozempic and Wegovy Have Lower Suicide Risk, Major Study Finds

Ozempic and Wegovy Have Lower Suicide Risk, Major Study Finds

FromOzempic Weightloss Unlocked


Ozempic and Wegovy Have Lower Suicide Risk, Major Study Finds

FromOzempic Weightloss Unlocked

ratings:
Length:
9 minutes
Released:
Jan 8, 2024
Format:
Podcast episode

Description

A major new study finds popular diabetes and weight loss drugs Ozempic and Wegovy, which contain the ingredient semaglutide, actually carry a lower risk of suicidal thoughts compared to other medications used to treat obesity and type 2 diabetes. However, the FDA is still investigating potential mental health side effects, so more long-term data is needed.
Released:
Jan 8, 2024
Format:
Podcast episode

Titles in the series (19)

Embark on a journey through the world of Ozempic – the innovative prescription injectable medication that's changing the game for individuals managing type 2 diabetes and seeking effective weight loss solutions. In this comprehensive guide, we delve deep into the science behind Ozempic, unveiling its fascinating mechanism of action and its remarkable impact on health.Explore how Ozempic, a GLP-1 receptor agonist, works in harmony with your body, mimicking the natural hormone GLP-1 to regulate blood sugar levels and curb those insatiable cravings. We'll unravel its profound effects on your overall well-being, shedding light on how it can be a potent ally in your fight against diabetes and obesity-related challenges.But every hero has its foes, and Ozempic is no exception. Learn about the potential side effects and rare risks associated with this medication to make informed decisions about your health.Join us in this illuminating journey, produced by the knowledge-driven team at Quiet Please Studios. Stay tuned, stay informed, and embrace the possibilities of a healthier future with Ozempic."